Description
A myeloperoxidase inhibitor (Ki = 346.74 nM in a cell-free assay); selective for MPO over TPO and a panel of more than 50 enzymes, receptors, transporters, and ion channels; inhibits MPO activity in isolated human whole blood (IC50 = 1.5 µM); reduces lung edema, decreases plasma levels of TNF-α, MCP-1/CCL2, MIP-2/CXCL2, and KC/CXCL1 and transiently increases and then reduces neutrophil levels in BALF in a mouse model of pulmonary immune complex vasculitis at 20 and 100 mg/kg
Formal name: 6-(2,5-dimethoxyphenyl)-3,4-dihydro-4-oxo-2-thioxo-1(2H)-pyrimidineacetamide
Synonyms: PF-06281355
Molecular weight: 321.4
CAS: 1435467-38-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cardiovascular System|Cardiovascular Diseases||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Immunology & Inflammation|Innate Immunity